1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Arrayjet Ltd
- Bjs Biotechnologies Ltd
- Breast Cancer Campaign
- Cancer Vaccines Ltd
- Randox Laboratories Ltd
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Summary
Almac Diagnostic Services Ltd (Almac Diagnostic Services), a subsidiary of Almac Group Ltd, is a medical diagnostic company that discovers, develops and commercializes diagnostic tests including companion diagnostics. The company provides products pipeline such as ColDx, DDRD, AADx, prostate Dx and MEK Dx, among others. It offers ColDx, a prognostic assay for stage II and III colon cancer, and DDRD, is a predictive assay for immune-oncology and DNA damaging agent. Almac Diagnostic Services provides pre-clinical biomarker discovery to companion diagnostic development including regulatory submissions and commercialization. The company provides applications such as patient selection, and are utilised in phase I to phase III registrational clinical trials. It operates laboratories in the US and the UK. Almac Diagnostic Services is headquartered in Craigavon, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Reasons to Buy:
Note: Some sections may be missing if data is unavailable for the company
Almac Diagnostic Services Ltd (Almac Diagnostic Services), a subsidiary of Almac Group Ltd, is a medical diagnostic company that discovers, develops and commercializes diagnostic tests including companion diagnostics. The company provides products pipeline such as ColDx, DDRD, AADx, prostate Dx and MEK Dx, among others. It offers ColDx, a prognostic assay for stage II and III colon cancer, and DDRD, is a predictive assay for immune-oncology and DNA damaging agent. Almac Diagnostic Services provides pre-clinical biomarker discovery to companion diagnostic development including regulatory submissions and commercialization. The company provides applications such as patient selection, and are utilised in phase I to phase III registrational clinical trials. It operates laboratories in the US and the UK. Almac Diagnostic Services is headquartered in Craigavon, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Almac Diagnostic Services Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Arrayjet Ltd
- Bjs Biotechnologies Ltd
- Breast Cancer Campaign
- Cancer Vaccines Ltd
- Randox Laboratories Ltd
Almac Diagnostic Services Ltd Company Overview
Almac Diagnostic Services Ltd - Major Products and Services
2-Gene qPCR LDT
ALM AADx Assay
Almac EMT Assay
Angiogenesis Subtype Diagnostic Assay
Diagnostic Test - Ovarian Cancer
DNA Damage Response Deficiency Assay - Breast Cancer
DNA Damage Response Deficiency Assay - Colorectal Cancer
DNA Damage Response Deficiency Assay - Esophageal Cancer
DNA Damage Response Deficiency Assay - Ovarian Cancer
NanoStrings’s nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay
Next-Generation Sequencing Based Companion Diagnostic Assay
Pan-Cancer Companion Diagnostic Assay
Predictive Assay - Immuno-oncology
Prognostic Test - Early Stage Lung Cancer
Prognostic Test - NSCLC
Prostate Cancer Metastatic Assay
RSPO3 CLIA Assay
Almac Diagnostic Services Ltd - Locations And Subsidiaries
Recent Developments
Appendix
List of Tables
List of Figures
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Randox Laboratories Ltd
- Cancer Vaccines Ltd
- Cambridge Clinical Laboratories Ltd
- Breast Cancer Campaign
- Bjs Biotechnologies Ltd
- Arrayjet Ltd
Note: Product cover images may vary from those shown